FB Rice names Melbourne biotech partners
Australian independent IP firm FB Rice has promoted two new Melbourne partners in a bid to strengthen its biotechnology and chemistry practice.
The company has named Dr Patrick McManamny and Dr Marcus Caulfield as its newest partners. Both appointees have been working at FB Rice since 2002.
Dr McManamny is part of the firm’s biotechnology team. He advises clients on patent validity and management issues, focusing on biological drugs such as antibodies and stem cells, as well as diagnostics and drug screening technologies.
Dr Caulfield’s expertise is in organic and polymer chemistry, and he advises companies in both the animal and human health segments.
Both new partners also have clients including universities, hospitals, cooperative research centres and research institutes.
FB Rice was founded over 60 years ago and has been operating in Melbourne for the past 20 years.
Inhaled form of blood thinner treats serious COVID infections
Heparin has traditionally been injected and used to treat blood clots, but the new study tested...
Next-gen therapies could treat high-grade gliomas
Government funding will enable researchers to test a suite of next-generation therapies they have...
Bacteriophage cocktail to combat superbugs
Entelli-02 is a five-phage cocktail designed specifically to target Enterobacter cloacae...
